TG Therapeutics | TGTX - Current Assets



TG Therapeutics reported $663.96M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Amgen USD 26.73B 195M Jun/2025
Ardelyx USD 351.57M 4.88M Jun/2025
Arrowhead Research USD 946.92M 188.3M Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Dynavax Technologies USD 785.71M 30.26M Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Novartis USD 25.94B 831M Jun/2025
PTC Therapeutics USD 2.27B 43.53M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
TG Therapeutics USD 663.96M 19.45M Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025